Weinstein Isabel, Kelava Augustin, Dausch Dieter, Seitz Berthold
Department of Ophthalmology (I.W., B.S.), Saarland University Medical Center (UKS), Homburg/Saar, Germany; Methods Center (A.K.), Eberhard Karls University Tübingen, Germany; and Praxis Prof. Dr. Dieter Dausch (D.D.), Amberg, Germany.
Eye Contact Lens. 2025 Mar 1;51(3):e123-e128. doi: 10.1097/ICL.0000000000001155. Epub 2024 Dec 10.
This study aimed to document the treatment success of eyelid hygiene with liposomal suspension using new diagnostic tools and to determine whether additional lipid substitution provided measurable benefits in meibomian gland dysfunction.
A single-center controlled, partially single masked study was conducted. Group A used eyelid hygiene only, whereas group B additionally applied a liposomal eye spray. Subjective perception using the Ocular Surface Disease Index (OSDI) questionnaire, measurement of tear film osmolarity, noninvasive tear film break-up time, assessment of the lipid layer, meibography, inspection of lid margins, assessment of the meibomian glands, and measurement of matrix-metallopeptidase-9 were collected at baseline and after 12 weeks.
Eighty-two patients were included and randomized into two groups. Both groups showed a decrease in OSDI score ( P <0.001), an increase in lipid layer thickness ( P <0.001), significant improvement in the degree of loss of meibomian glands ( P <0.001), in the damage pattern of the eyelid margins ( P <0.001), in the quality of meibomian gland secretion, and in matrix-metallopeptidase-9 after 12 weeks.
Our study confirms the success of treatment with eyelid hygiene measures using a liposomal suspension. The additional benefit of lipid substitution was not significant after 12 weeks of treatment.
本研究旨在利用新的诊断工具记录脂质体混悬液进行眼睑清洁治疗的成功率,并确定额外的脂质替代疗法在睑板腺功能障碍中是否能带来可测量的益处。
开展了一项单中心对照、部分单盲研究。A组仅采用眼睑清洁,而B组额外使用脂质体眼喷雾。在基线期和12周后收集使用眼表疾病指数(OSDI)问卷的主观感受、泪膜渗透压测量、非侵入性泪膜破裂时间、脂质层评估、睑板腺造影、睑缘检查、睑板腺评估以及基质金属蛋白酶-9的测量结果。
纳入82例患者并随机分为两组。两组在12周后OSDI评分均降低(P<0.001),脂质层厚度增加(P<0.001),睑板腺缺失程度、睑缘损伤模式、睑板腺分泌质量以及基质金属蛋白酶-9均有显著改善(P<0.001)。
我们的研究证实了使用脂质体混悬液的眼睑清洁措施治疗的成功。治疗12周后,脂质替代疗法的额外益处并不显著。